Main menu

Clinical Study Report Synopses

Clinical Study Report Synopses

Clinical Study Reports (CSRs) are often created as part of the process of submitting applications for new medical treatments to regulators. CSRs answer questions such as: Why was the trial done? What were the important questions asked in the trial? What were the results? CSRs also include extensive details on the course of treatment for patients, the medical information collected from the patients as part of the research, and demographic data, as well as other kinds of information to explain how the trial was conducted and results were analyzed.

Because CSRs contain information that could be valuable to researchers, Pfizer is making electronic synopses of CSRs publicly available on this website. These synopses have been prepared for public use. They include the synopsis of the CSR submitted to the regulatory agency. 

Any data that could be used to identify individual patients has been removed.  Synopses will be posted for trials either initiated after Sept. 27, 2007, or initiated on or before that date and were still ongoing as of Dec. 26, 2007.  To access the synopses that have been posted to date,* press the "Show Results" button to see the full list, or filter the results using the fields below.

OR

From 
E.g., 2014-08-21
To 
E.g., 2014-08-21
From 
E.g., 2014-08-21
To 
E.g., 2014-08-21

CSR footnotes

* As of December 4, 2013, synopses are available on this website for 200 trials out of approximately 600 trials within the scope of Pfizer’s Clinical Data Access policy. The remaining CSR synopses will be completed and posted during 2014.

** The NCT Number is the ClinicalTrials.gov unique identifier for a specific study.

Responsible Data Sharing

Pfizer’s practices adhere to the principles for responsible data sharing laid out by the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the Pharmaceutical Research and Manufacturers of America (PhRMA).